The Laryngoscope · 2018
Recurrent laryngeal nerve paralysis after thyroid cancer surgery and intraoperative nerve monitoring.
Оценочное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mizuno Kayoko, Takeuchi Masato, Kanazawa Yuji, Kitamura Morimasa, Ide Kazuki, Omori Koichi, Kawakami Koji
Аннотация
OBJECTIVES/HYPOTHESIS: This study aimed to investigate the risk of postoperative recurrent laryngeal nerve paralysis (RLNP) with and without the use of intraoperative nerve monitoring (IONM) during thyroid cancer surgery.
STUDY DESIGN: Retrospective cohort study.
METHODS: This study utilized a nationwide claims database in Japan. Patients who underwent thyroid cancer surgery with and without IONM were included, and postoperative RLNP incidence was compared.
RESULTS: The study included 5,804 patients. Multivariable logistic regression analysis revealed that use of IONM was not associated with increased RLNP risk (odds ratio: 1.15; 95% confidence interval: 0.67-1.96). There was no significant effect on RLNP prevention when stratified by tumor or nodal classification. Rather, the patients who had T4 or N1b classifications who received IONM had higher incidences of RLNP.
CONCLUSIONS: Use of IONM did not significantly reduce the risk of RLNP. The results for the T4 and N1b populations may be explained by indication bias or unmeasured confounders.
LEVEL OF EVIDENCE: NA Laryngoscope, 129:1954-1960, 2019.
STUDY DESIGN: Retrospective cohort study.
METHODS: This study utilized a nationwide claims database in Japan. Patients who underwent thyroid cancer surgery with and without IONM were included, and postoperative RLNP incidence was compared.
RESULTS: The study included 5,804 patients. Multivariable logistic regression analysis revealed that use of IONM was not associated with increased RLNP risk (odds ratio: 1.15; 95% confidence interval: 0.67-1.96). There was no significant effect on RLNP prevention when stratified by tumor or nodal classification. Rather, the patients who had T4 or N1b classifications who received IONM had higher incidences of RLNP.
CONCLUSIONS: Use of IONM did not significantly reduce the risk of RLNP. The results for the T4 and N1b populations may be explained by indication bias or unmeasured confounders.
LEVEL OF EVIDENCE: NA Laryngoscope, 129:1954-1960, 2019.
Предметные рубрики MeSH
AdultAgedDatabases, FactualFemaleHumansIncidenceIntraoperative Neurophysiological MonitoringJapanLogistic ModelsMaleMiddle AgedMultivariate AnalysisPostoperative ComplicationsRecurrent Laryngeal NerveRecurrent Laryngeal Nerve InjuriesRetrospective StudiesThyroid NeoplasmsThyroidectomyTreatment OutcomeVocal Cord ParalysisYoung Adult